Manufacturing & lab demand help WuXi beat Q1 guidance
WuXi PharmaTech beat expectations in the first quarter as strong demand for manufacturing and laboratory services continued.
WuXi PharmaTech beat expectations in the first quarter as strong demand for manufacturing and laboratory services continued.
The US FDA has changed its sterility testing requirements for biological products to give manufacturers greater flexibility and encourage use of ‘state-of-the-art’ analysis methods.
in-PharmaTechnologist presents the latest job moves in the pharmaceutical industry including news from Incline, Tonix, and ABPI.
DSM ended a five year search for a buyer for its maleic anhydride derivatives business last week after bids failed to meet expectations.
Marken is looking at setting up a home delivery service as a further expansion of its clinical trial and logistics offering.
The ICH has sent its Q11 guidelines on APIs to regulatory bodies in the US, European Union and Japan for adoption.
Catalent reported a dip in third quarter contract packaging sales and volumes after a client insourced work.